Baxter International is a global medtech and biopharma company. Through its BioPharma Solutions (BPS) division, Baxter operates as a major CDMO providing sterile fill/finish manufacturing services. BPS invested over $150M in expanding sterile fill/finish capacity at its Bloomington, Indiana facility. Note: Baxter has signed a definitive agreement to divest its BioPharma Solutions business. Baxter has 308 FDA-approved products, extensive manufacturing facilities worldwide, and 93 FDA inspections on record.
sterile fill/finish manufacturing, parenteral drug manufacturing, lyophilization, aseptic processing, IV solutions, injectable drug delivery
7 sites worldwide
Involvement in 8 clinical trials
No reviews available yet.
No documents available.